|

Statins and ARBs on Rheumatoid Activity

RECRUITINGPhase 3Sponsored by Sherief Abd-Elsalam
Actively Recruiting
PhasePhase 3
SponsorSherief Abd-Elsalam
Started2018-10-01
Est. completion2025-12-01
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03770702

Summary

Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Rheumatoid arthritis.

Exclusion Criteria:

* Pregnant or lactating
* Hepatic or renal impairment.

Conditions2

ArthritisRheumatoid Arthritis

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.